Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters

Database
Language
Publication year range
1.
Neural Plast ; 2016: 4235898, 2016.
Article in English | MEDLINE | ID: mdl-27547454

ABSTRACT

One of the most challenging questions in neuroscience is to dissect how learning and memory, the foundational pillars of cognition, are grounded in stable, yet plastic, gene expression states. All known epigenetic mechanisms such as DNA methylation and hydroxymethylation, histone modifications, chromatin remodelling, and noncoding RNAs regulate brain gene expression, both during neurodevelopment and in the adult brain in processes related to cognition. On the other hand, alterations in the various components of the epigenetic machinery have been linked to well-known causes of intellectual disability disorders (IDDs). Two examples are Down Syndrome (DS) and Fragile X Syndrome (FXS), where global and local epigenetic alterations lead to impairments in synaptic plasticity, memory, and learning. Since epigenetic modifications are reversible, it is theoretically possible to use epigenetic drugs as cognitive enhancers for the treatment of IDDs. Epigenetic treatments act in a context specific manner, targeting different regions based on cell and state specific chromatin accessibility, facilitating the establishment of the lost balance. Here, we discuss epigenetic studies of IDDs, focusing on DS and FXS, and the use of epidrugs in combinatorial therapies for IDDs.


Subject(s)
Cognition/physiology , Down Syndrome/genetics , Epigenesis, Genetic/genetics , Fragile X Syndrome/genetics , Gene-Environment Interaction , Genetic Therapy/trends , Antioxidants/pharmacology , Antioxidants/therapeutic use , Catechin/analogs & derivatives , Catechin/pharmacology , Catechin/therapeutic use , Cognition/drug effects , DNA Methylation/genetics , Down Syndrome/psychology , Down Syndrome/therapy , Epigenesis, Genetic/drug effects , Fragile X Syndrome/psychology , Fragile X Syndrome/therapy , Genetic Therapy/methods , Humans , Intellectual Disability/genetics , Intellectual Disability/psychology , Intellectual Disability/therapy , Protein Interaction Domains and Motifs/genetics
2.
J Intern Med ; 276(5): 454-69, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25069756

ABSTRACT

BACKGROUND: High mobility group box 1 (HMGB1) is a small nuclear protein with two functions. In the nucleus, it helps to wrap DNA around nucleosomes. When secreted, it recruits inflammatory cells and induces cytokine production. Before HMGB1 is secreted from inflammatory cells, it relocates to the cytoplasm, which partially or totally depletes cell nuclei of HMGB1. We previously showed that cells lacking HMGB1 contain 20% fewer nucleosomes and 30% more RNA transcripts levels genome-wide. OBJECTIVE: We hypothesized that the depletion of nuclear HMGB1 plays a role in inflammation that can enhance or complement the role of extracellular HMGB1. METHODS: We analysed the transcriptional profile of wild-type and Hmgb1-/- mouse embryonic fibroblasts (MEFs) as a proxy for cells that have lost HMGB1 from their nuclei. We explored the transcriptome of wild-type and Hmgb1-/- macrophages differentiated in the presence of granulocyte-macrophage colony-stimulating factor, before and after exposure to LPS/IFN-γ. In the same cells, histones and nuclear HMGB1 were quantified. RESULTS: We found that Hmgb1-/- MEFs show a transcriptional profile associated with stress and inflammation responses. Moreover, wild-type macrophages that have secreted HMGB1 because of LPS/IFN-γ exposure rapidly reduce their histone content as much as cells that genetically lack HMGB1. Importantly, unstimulated Hmgb1-/- macrophages activate transcriptional pathways associated with cell migration and chemotaxis. CONCLUSIONS: We suggest that nucleosome loss is an early event that facilitates transcriptional responses of macrophages to inflammation, particularly chemotaxis. HMGB1's dual roles in the nucleus and in the extracellular space appear to be complementary.


Subject(s)
HMGB1 Protein/metabolism , Inflammation/metabolism , Macrophages/metabolism , Nucleosomes/metabolism , Animals , Cell Line , Cell Nucleus/physiology , Chemotaxis , Histones/genetics , Histones/metabolism , Inflammation/genetics , Lipopolysaccharides/pharmacology , Liver/cytology , Liver/embryology , Macrophages/cytology , Macrophages/drug effects , Transcription, Genetic
3.
Sci Rep ; 10(1): 16023, 2020 09 29.
Article in English | MEDLINE | ID: mdl-32994493

ABSTRACT

Down syndrome (DS) is the main genetic cause of intellectual disability due to triplication of human chromosome 21 (HSA21). Although there is no treatment for intellectual disability, environmental enrichment (EE) and the administration of green tea extracts containing epigallocatechin-3-gallate (EGCG) improve cognition in mouse models and individuals with DS. Using proteome, and phosphoproteome analysis in the hippocampi of a DS mouse model (Ts65Dn), we investigated the possible mechanisms underlying the effects of green tea extracts, EE and their combination. Our results revealed disturbances in cognitive-related (synaptic proteins, neuronal projection, neuron development, microtubule), GTPase/kinase activity and chromatin proteins. Green tea extracts, EE, and their combination restored more than 70% of the phosphoprotein deregulation in Ts65Dn, and induced possible compensatory effects. Our downstream analyses indicate that re-establishment of a proper epigenetic state and rescue of the kinome deregulation may contribute to the cognitive rescue induced by green tea extracts.


Subject(s)
Camellia sinensis/chemistry , Cognition/drug effects , Down Syndrome/psychology , Plant Extracts/administration & dosage , Proteomics/methods , Animals , Catechin/administration & dosage , Catechin/analogs & derivatives , Catechin/pharmacology , Chromatography, Liquid , Disease Models, Animal , Down Syndrome/genetics , Epigenesis, Genetic/drug effects , Hippocampus/metabolism , Mice , Mice, Transgenic , Phosphorylation/drug effects , Plant Extracts/chemistry , Plant Extracts/pharmacology , Protein Interaction Maps/drug effects , Tandem Mass Spectrometry
4.
eNeuro ; 5(6)2018.
Article in English | MEDLINE | ID: mdl-30637329

ABSTRACT

Obesogenic diets lead to overeating and obesity by inducing the expression of genes involved in hedonic and homeostatic responses in specific brain regions. However, how the effects on gene expression are coordinated in the brain so far remains largely unknown. In our study, we provided mice with access to energy-dense diet, which induced overeating and overweight, and we explored the transcriptome changes across the main regions involved in feeding and energy balance: hypothalamus, frontal cortex, and striatum. Interestingly, we detected two regulatory processes: a switch-like regulation with differentially expressed (DE) genes changing over 1.5-fold and "fine-tuned" subtler changes of genes whose levels correlated with body weight and behavioral changes. We found that genes in both categories were positioned within specific topologically associated domains (TADs), which were often differently regulated across different brain regions. These TADs were enriched in genes relevant for the physiological and behavioral observed changes. Our results suggest that chromatin structure coordinates diet-dependent transcriptional regulation.


Subject(s)
Brain/metabolism , Chromatin/metabolism , Gene Expression Regulation/physiology , Gene Expression/physiology , Homeostasis/physiology , Overweight/pathology , Overweight/physiopathology , Animals , Compulsive Behavior , Computational Biology , Correlation of Data , Diet/adverse effects , Feeding Behavior/physiology , Female , Grooming , Mice , Mice, Inbred C57BL , Microarray Analysis , Models, Biological , Nesting Behavior/physiology , Overweight/etiology
5.
Sci Rep ; 6: 24141, 2016 Apr 11.
Article in English | MEDLINE | ID: mdl-27063004

ABSTRACT

Long noncoding RNAs (lncRNAs) are non-protein coding RNAs regulating gene expression. Although for some lncRNAs a relevant role in hypoxic endothelium has been shown, the regulation and function of lncRNAs is still largely unknown in the vascular physio-pathology. Taking advantage of next-generation sequencing techniques, transcriptomic changes induced by endothelial cell exposure to hypoxia were investigated. Paired-end sequencing of polyadenylated RNA derived from human umbilical vein endothelial cells (HUVECs) exposed to 1% O2 or normoxia was performed. Bioinformatics analysis identified ≈2000 differentially expressed genes, including 122 lncRNAs. Extensive validation was performed by both microarray and qPCR. Among the validated lncRNAs, H19, MIR210HG, MEG9, MALAT1 and MIR22HG were also induced in a mouse model of hindlimb ischemia. To test the functional relevance of lncRNAs in endothelial cells, knockdown of H19 expression was performed. H19 inhibition decreased HUVEC growth, inducing their accumulation in G1 phase of the cell cycle; accordingly, p21 (CDKN1A) expression was increased. Additionally, H19 knockdown also diminished HUVEC ability to form capillary like structures when plated on matrigel. In conclusion, a high-confidence signature of lncRNAs modulated by hypoxia in HUVEC was identified and a significant impact of H19 lncRNA was shown.


Subject(s)
Cell Hypoxia , RNA, Long Noncoding/metabolism , Animals , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Disease Models, Animal , G1 Phase Cell Cycle Checkpoints , High-Throughput Nucleotide Sequencing , Human Umbilical Vein Endothelial Cells , Humans , Immunohistochemistry , Ischemia/genetics , Ischemia/metabolism , Ischemia/pathology , Male , Mice , Mice, Inbred C57BL , Oligoribonucleotides, Antisense , RNA Interference , RNA, Long Noncoding/antagonists & inhibitors , RNA, Long Noncoding/chemistry , RNA, Long Noncoding/genetics , Sequence Analysis, RNA , Transcriptome
SELECTION OF CITATIONS
SEARCH DETAIL